DARE Latest Press Releases

-- October 30, 2026 --

Dar Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum Globe Newswire 8:32 AM

-- October 28, 2026 --

Dar Bioscience Addresses New National Focus on Women's Health in Virtual Investor 'What This Means' Discussion Globe Newswire 8:47 AM

-- October 26, 2026 --

Dar Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly Globe Newswire 8:32 AM

-- October 19, 2026 --

Dar Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer Globe Newswire 8:56 AM

-- October 13, 2026 --

Dar Bioscience Launches 'CEO Corner' Video Series to Highlight the Company's Pipeline of Women's Health Innovations, Corporate Strategy and Opportunities Globe Newswire 9:15 AM

-- October 8, 2026 --

Dar Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting Globe Newswire 9:15 AM

-- September 28, 2026 --

Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection Globe Newswire 8:20 AM

-- September 14, 2026 --

Dar Bioscience Announces Peer-Reviewed Publication of Phase 1 Sildenafil Cream Study in Men Demonstrating Substantially Lower Systemic Exposure Versus Oral Sildenafil Globe Newswire 8:50 AM

-- September 11, 2026 --

Dar Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand Globe Newswire 6:55 AM

-- August 31, 2026 --

Dar Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth Globe Newswire 8:44 AM

-- August 27, 2026 --

JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs ACCESS Newswire 9:01 AM

Dar Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor 'Why Now' On-Demand Series Globe Newswire 9:01 AM

-- August 26, 2026 --

Dar Bioscience's Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society Globe Newswire 8:45 AM

-- August 25, 2026 --

Dar Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment Globe Newswire 8:55 AM

-- August 18, 2026 --

DAR Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 '50 Over 50: Innovation' List Globe Newswire 9:02 AM

-- August 14, 2026 --

Dar Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Globe Newswire 12:45 PM

-- August 13, 2026 --

Dar Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women's Health Strategy Advances Globe Newswire 4:01 PM

-- August 6, 2026 --

Dar Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026 Globe Newswire 9:05 AM

-- July 28, 2026 --

Dar Bioscience Expands Access Options for DARE to PLAY and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx Globe Newswire 8:34 AM

-- July 20, 2026 --

Dar Bioscience Launches Nationwide Virtual Bus Tour Webinar Series to Showcase Commercial Strategy and Growth Opportunities Globe Newswire 9:01 AM

-- July 9, 2026 --

Dar Bioscience CEO, Sabrina Martucci Johnson, to Participate in Virtual Investor Closing Bell Event Globe Newswire 8:43 AM

-- July 1, 2026 --

Dar Bioscience Announces Flora Sync LF5 Is Now Available Through Its Direct-to-Consumer Platform Globe Newswire 8:55 AM

-- June 25, 2026 --

Dar Bioscience Highlights Revenue Opportunity as CEO Discusses Upcoming Launch of Flora Sync LF5 in Virtual Investor 'What This Means' Segment Globe Newswire 9:05 AM

-- June 18, 2026 --

Dar Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026 Globe Newswire 9:20 AM

-- June 4, 2026 --

Dar Bioscience Announces the Upcoming Launch of Flora Sync LF5 Vaginal Probiotic Capsules Globe Newswire 8:00 AM